查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446448

CRM 設備（心律管理設備）市場規模、佔有率、趨勢分析報告：按產品、地區和細分市場預測，2024-2030 年

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Products (Pacemakers (Implantable, External), Defibrillators, Cardiac Resynchronization Therapy), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

CRM設備（心律管理設備）市場成長與趨勢：

Grand View Research的最新報告顯示，到2030年，全球CRM設備市場規模預計將達到294.6億美元。

預計 2024 年至 2030 年，該市場將以 6.9% 的複合年成長率擴張。推動市場的主要因素包括由於心血管疾病盛行率的增加而擴大採用心律管理（CRM）設備。根據美國疾病管制與預防美國(CDC) 的數據，截至 2021 年 9 月，每年約有 659,000 名美國死於心臟病。在 COVID-19 大流行期間，市場受到了負面影響，因為包括非必要的心血管手術在內的選擇性手術被推遲或取消。

美敦Medtronic）、雅培（Abbott）和波士頓科學公司（Boston Scientific Corporation）等市場主要企業的心律管理業務在全球範圍內遭受了巨大損失。因此，2020年市場出現負成長。解決心臟麻痹的需求不斷成長，導致各類心律管理設備不斷創新。植入式設備的創新還包括旨在提高患者舒適度的產品，例如皮下和經靜脈設備。瑞典交通局實施了一項試點計劃，旨在使用無人機運送 AED。這可以減少 AED 的遞送時間並增加及時治療的生存機會。

因此，由於技術進步和產品創新，市場預計將成長。革命性技術進步的跡象正在迅速改變市場。這種擴張創造了利潤豐厚的可能性。領先公司不斷增加的研發支出和新產品的推出進一步支持了成長。例如，2020 年 10 月，雅培在印度推出了新的 ICD 和 CRT-D，擴大了在產品系列。該公司還於 2020 年 2 月獲得了 Gallant ICD 和 CRT-D 設備的 CE 標誌核准。這些因素正在推動市場成長。主要市場參與者提供廣泛的產品，因此在市場上佔有重要佔有率。

CRM 設備市場報告亮點

  • 2023年市場規模為185.7億美元，預計在預測期內複合年成長率為6.9%。
  • 從產品來看，心臟去顫器由於全球採用率較高，在 2023 年佔據市場主導地位，佔有率超過 39.39%。
  • 在體外心臟去顫器領域，自動體外心臟去顫器領域用於起搏、傳送刺激心臟收縮的脈衝電流以及將心律不整和心搏過速轉變為正常心率的去心房顫動等應用，其收益佔有率最高。因其優點而分享。
  • 2023年，由於心血管疾病盛行率上升以及CRM設備的高普及，北美佔據了市場的主導佔有率。
  • 由於中國和印度等新興經濟體的存在，預計亞太地區在預測期內將呈現良好的成長。

目錄

第1章調查方法和範圍

第 2 章 CRM 設備市場：執行摘要

  • 市場概述
  • 產品簡介
  • 競爭形勢概覽

第 3 章 CRM 設備市場：變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 心血管疾病盛行率增加
    • 對微創手術的偏好增加
  • 市場限制因素分析
    • 與設備相關的高成本
  • CRM設備市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析
    • 價格分析

第 4 章 CRM 設備：產品估算/趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 按產品分類的全球 CRM 設備市場展望
  • 2018年至2030年市場規模、預測與趨勢分析
    • 心律調節器
    • 心臟去顫器
    • CRT

第5章區域業務分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • Physio-Control, Inc.
    • Medtronic, plc
    • ABBOTT
    • Boston Scientific Corporation
    • Schiller
    • Koninklijke Philips NV
    • Biotronik
    • Progetti Srl
    • Zoll Medical Corporation
    • LivaNova Plc
Product Code: GVR-2-68038-315-7

Cardiac Rhythm Management Devices Market Growth & Trends:

The global cardiac rhythm management devices market size is anticipated to reach USD 29.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.9% from 2024 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.

Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

Cardiac Rhythm Management Devices Market Report Highlights:

  • The market was valued at USD 18.57 billion in 2023 and is expected to expand at a CAGR of 6.9% during the forecast period
  • By product, defibrillators dominated the market with a share of over 39.39% in 2023 due to their high adoption globally
  • In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat
  • In 2023, North America held the dominant share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices
  • Asia Pacific region is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Cardiac Rhythm Management Devices Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cardiac Rhythm Management Devices Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing prevalence of cardiovascular disease
    • 3.4.2. Increasing preference for minimally invasive procedures
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with the devices
  • 3.6. Cardiac Rhythm Management Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape
    • 3.6.3. Pricing Analysis

Chapter 4. Cardiac Rhythm Management Devices: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Cardiac Rhythm Management Devices Market By Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
    • 4.4.1. Pacemakers
      • 4.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.1.1.1. Implantable
      • 4.4.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.1.1.2. External
      • 4.4.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.2. Defibrillators
      • 4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1. Implantable Cardioverter Defibrillators (ICD)
      • 4.4.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1.1.1. S-ICD
      • 4.4.2.1.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1.1.2. T-ICD
      • 4.4.2.1.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2. External Defibrillator
      • 4.4.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.1. Manual External Defibrillator
      • 4.4.2.1.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.2. Automatic External Defibrillator
      • 4.4.2.1.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.3. Wearable Cardioverter Defibrillator
      • 4.4.2.1.2.1.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.3. Cardiac Resynchronization Therapy (CRT)
      • 4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.3.1.1. CRT-Defibrillator
      • 4.4.3.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.3.1.2. CRT-Pacemakers
      • 4.4.3.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Competitive Scenario
      • 5.5.1.3. Regulatory Framework
      • 5.5.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Competitive Scenario
      • 5.6.1.3. Regulatory Framework
      • 5.6.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.3. Spain
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.6. Denmark
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 5.6.6.5.
    • 5.6.7. Sweden
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.8. Norway
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Competitive Scenario
      • 5.6.8.3. Regulatory Framework
      • 5.6.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key Country Dynamics
      • 5.7.1.2. Competitive Scenario
      • 5.7.1.3. Regulatory Framework
      • 5.7.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.4. South Korea
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.5. Thailand
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.6. Australia
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key Country Dynamics
      • 5.8.1.2. Competitive Scenario
      • 5.8.1.3. Regulatory Framework
      • 5.8.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.8.2. Mexico
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. Mexico Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. MEA Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory Framework
      • 5.9.2.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory Framework
      • 5.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Competitive Scenario
      • 5.9.4.3. Regulatory Framework
      • 5.9.4.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Competitive Scenario
      • 5.9.5.3. Regulatory Framework
      • 5.9.5.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company /Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of Key Distributors And Channel Partners
    • 6.3.2. Key Customers
    • 6.3.3. Key Company Market Share Analysis, 2023
    • 6.3.4. Physio-Control, Inc.
      • 6.3.4.1. Overview
      • 6.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Medtronic, plc
      • 6.3.5.1. Overview
      • 6.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. ABBOTT
      • 6.3.6.1. Overview
      • 6.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Boston Scientific Corporation
      • 6.3.7.1. Overview
      • 6.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Schiller
      • 6.3.8.1. Overview
      • 6.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Koninklijke Philips N.V
      • 6.3.9.1. Overview
      • 6.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.9.3. Product Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Biotronik
      • 6.3.10.1. Overview
      • 6.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.10.3. Product Benchmarking
      • 6.3.10.4. Strategic Initiatives
    • 6.3.11. Progetti Srl
      • 6.3.11.1. Overview
      • 6.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.11.3. Product Benchmarking
      • 6.3.11.4. Strategic Initiatives
    • 6.3.12. Zoll Medical Corporation
      • 6.3.12.1. Overview
      • 6.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.12.3. Product Benchmarking
      • 6.3.12.4. Strategic Initiatives
    • 6.3.13. LivaNova Plc
      • 6.3.13.1. Overview
      • 6.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.13.3. Product Benchmarking
      • 6.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Canada Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Europe Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 7 Europe Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 UK Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Germany Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 France Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Italy Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Spain Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 Sweden Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 Norway Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Denmark Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Japan Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 China Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 India Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Australia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 South Korea Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Thailand Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Brazil Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Mexico Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Argentina Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 MEA Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 30 MEA Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 South Africa Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 UAE Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary Interviews in APAC
  • Fig. 7 Primary Interviews in Latin America
  • Fig. 8 Primary Interviews in MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-chain-based Sizing & Forecasting
  • Fig. 11 QFD Modeling for Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Cardiac Rhythm Management Devices Market: Market Outlook
  • Fig. 14 Cardiac Rhythm Management Devices Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Cardiac Rhythm Management Devices Market Driver Impact
  • Fig. 20 Cardiac Rhythm Management Devices Market Restraint Impact
  • Fig. 21 Cardiac Rhythm Management Devices Market Strategic Initiatives Analysis
  • Fig. 22 Cardiac Rhythm Management Devices Market: Product Movement Analysis
  • Fig. 23 Cardiac Rhythm Management Devices Market: Product Outlook and Key Takeaways
  • Fig. 24 Pacemakers Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Defibrillators Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Cardiac Resynchronization Therapy (CRT) Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Global Cardiac Rhythm Management Devices Market: Regional Movement Analysis
  • Fig. 28 Global Cardiac Rhythm Management Devices Market: Regional Outlook and Key Takeaways
  • Fig. 29 Global Cardiac Rhythm Management Devices Market Share and Leading Players
  • Fig. 30 North America Market Share and Leading Players
  • Fig. 31 Europe Market Share and Leading Players
  • Fig. 32 Asia Pacific Market Share and Leading Players
  • Fig. 33 Latin America Market Share and Leading Players
  • Fig. 34 Middle East & Africa Market Share and Leading Players
  • Fig. 35 North America, By Country
  • Fig. 36 North America
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 U.S.
  • Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Canada
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Europe
  • Fig. 43 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 UK
  • Fig. 45 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Germany
  • Fig. 47 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 France
  • Fig. 49 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Italy
  • Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Spain
  • Fig. 53 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Denmark
  • Fig. 55 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Sweden
  • Fig. 57 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Norway
  • Fig. 59 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 China
  • Fig. 63 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Japan
  • Fig. 65 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 India
  • Fig. 67 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Thailand
  • Fig. 69 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 South Korea
  • Fig. 71 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 72 Australia
  • Fig. 73 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 74 Latin America
  • Fig. 75 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 76 Brazil
  • Fig. 77 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 78 Mexico
  • Fig. 79 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 80 Argentina
  • Fig. 81 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 84 South Africa
  • Fig. 85 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 88 UAE
  • Fig. 89 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait Market Estimates and Forecasts, 2018 - 2030
  • Fig. 92 Market Share of Key Market Players- Cardiac Rhythm Management Devices Market